Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edesa Biotech Inc EDSA

Healthcare Biotechnology
Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. The Company’s advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. It is evaluating EB05 in a Phase III study as a... see more

Recent & Breaking News (NDAQ:EDSA)

Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region

Marketwired January 11, 2017

Stellar Biotechnologies to Present at Biotech Showcase Conference

Marketwired January 4, 2017

Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results

Marketwired December 14, 2016

Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call

Marketwired December 12, 2016

Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors

Marketwired December 9, 2016

Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference

Marketwired December 1, 2016

Stellar Board Member and Pharma Expert to Join Executive Team

Marketwired October 24, 2016

Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up

Marketwired October 5, 2016

Stellar Biotechnologies to Present at International Aquaculture Symposium

Marketwired September 21, 2016

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  September 16, 2016

Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference

Marketwired September 6, 2016

Stellar Biotechnologies Reports Third Quarter 2016 Financial Results and Operational Highlights

Marketwired August 9, 2016

Stellar Biotechnologies Announces Third Quarter 2016 Corporate Update Conference Call

Marketwired August 4, 2016

Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France

Marketwired July 19, 2016

Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids

GlobeNewswire July 19, 2016

Stellar Biotechnologies Announces Closing of Registered Direct Offering

Marketwired July 6, 2016

Stellar Biotechnologies to Present at LD Micro Invitational Conference

Marketwired June 2, 2016